Utama › Adenokarsinoma Esofagus › Michigan › Ann Arbor
Kajian klinikal Adenokarsinoma Esofagus di Ann Arbor, MI
7 kajian untuk Adenokarsinoma Esofagus sedang mencari peserta di lokasi dalam dan sekitar Ann Arbor (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Mengambil pesertaFasa 2/3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauh
- Chelsea Hospital, Chelsea · 15 mi jauh
- dan 3 lagi
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Mengambil pesertaFasa 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi jauh
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauh
- dan 4 lagi
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Mengambil pesertaFasa 1/2
- University of Michigan, Ann Arbor
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Mengambil pesertaFasa 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Mengambil peserta
- University of Michigan, Ann Arbor
Obeticholic Acid for Prevention in Barrett's Esophagus
Mengambil pesertaFasa 2
- University of Michigan Rogel Cancer Center, Ann Arbor
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Mengambil pesertaFasa 2
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Kajian Adenokarsinoma Esofagus di bandar lain
- New York City, NY18 kajian
- Boston, MA13 kajian
- Houston, TX12 kajian
- Nashville, TN11 kajian
- Arlington, VA11 kajian
- Durham, NC10 kajian
- Rochester, MN9 kajian
- Baldwin Park, CA9 kajian
- St. Louis, MO9 kajian
- Jacksonville, FL9 kajian
- Queens, NY9 kajian
- Los Angeles, CA9 kajian
Kajian lain di Ann Arbor
- Kanser Payudara27 kajian
- Kanser Prostat27 kajian
- Kanser Paru-paru Bukan Sel Kecil26 kajian
- Kanser (semua jenis)25 kajian
- Kanser Paru-paru23 kajian
- Kanser Kolorektal23 kajian
- Kegagalan Jantung22 kajian
- Leukemia Mieloid Akut17 kajian
- Penyakit Kardiovaskular16 kajian
- Kanser Pankreas14 kajian
- Melanoma12 kajian
- Strok12 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.